Merck Newswire

Merck Newswire

Comprehensive Real-Time News Feed for Merck .

Results 1 - 20 of 5,503 in Merck

  1. Adams Express Co Buys Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, Johnson & ...Read the original story w/Photo

    35 min ago | GuruFocus.com

    Baltimore, MD, based Investment company Adams Express Co buys Bristol-Myers Squibb Company, Bristol-Myers Squibb Company, Johnson & Johnson, Citigroup Inc, McKesson Corp, Altria Group Inc, DXC Technology Co, AT&T Inc, Pioneer Natural Resources Co, SPDR Select Sector Fund - Industrial, sells Merck Inc, Wells Fargo, NextEra Energy Inc, NextEra Energy Inc, Biogen Inc during the 3-months ended 2017-06-30, according to the most recent filings of the investment company, Adams Express Co. As of 2017-06-30, Adams Express Co owns 206 stocks with a total value of $1.7 billion.

    Comment?

  2. Merck KGaA (FRA:MRK) Given a 116.00 Price Target at Warburg ResearchRead the original story w/Photo

    1 hr ago | IntersportsWire

    ... analysts also recently commented on MRK. Independent Research GmbH set a 110.00 ($126.44) target price on shares of Merck KGaA and gave the stock a neutral rating in a research note on Thursday, March 9th. Morgan Stanley set a 103.00 ($118.39) ...

    Comment?

  3. Merck Receives Tentative FDA Approval for Lantus Follow-onRead the original story w/Photo

    2 hrs ago | JD Supra

    ... is subject to an automatic stay pending the resolution of suit brought by Sanofi. Lusduna Nexvue was developed by Merck with funding from Samsung Bioepis. Like all transitional biologics, we expect the NDA for Lusduna Nexvue will be transitioned to ...

    Comment?

  4. Vaughan Nelson Investment Management L.P. Has $1,038,000 Position in Merck & Company, Inc.Read the original story w/Photo

    2 hrs ago | IntersportsWire

    Vaughan Nelson Investment Management L.P. held its stake in Merck & Company, Inc. during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,200 shares of the company's stock at the end of the second quarter.

    Comment?

  5. Merck & Co. And Pfizer Collaborate With Corning To Modernize Pharmaceutical Glass PackagingRead the original story

    22 hrs ago | BioSpace

    ... to medicines essential to public health. Deep pharmaceutical formulation and manufacturing process insights from Merck and Pfizer, in combination with Corning's glass science and precision forming capabilities helped deliver an exceptional glass ...

    Comment?

  6. BerganKDV Wealth Management LLC Acquires 813 Shares of Merck & Company, Inc.Read the original story w/Photo

    5 hrs ago | Daily Political

    BerganKDV Wealth Management LLC raised its stake in shares of Merck & Company, Inc. by 5.8% during the second quarter, Holdings Channel reports. The institutional investor owned 14,758 shares of the company's stock after buying an additional 813 shares during the period.

    Comment?

  7. Altfest L J & Co Inc Buys SPDR Select Sector Fund - Financial, SPDR Select Sector Fund - ...Read the original story w/Photo

    6 hrs ago | GuruFocus.com

    Altfest L J & Co Inc Buys SPDR Select Sector Fund - Financial, SPDR Select Sector Fund - Consumer Staples, SPDR Select Sector Fund - Consumer Discretionary, Sells Gould Investors LP, Schwab U.S. Large-Cap, iShares MSCI EAFE Value New York, NY, based Investment company Altfest L J & Co Inc buys SPDR Select Sector Fund - Financial, SPDR Select Sector Fund - Consumer Staples, SPDR Select Sector Fund - Consumer Discretionary, Pfizer Inc, Vanguard Energy, Materials Select Sector SPDR, United Parcel Service Inc, United Parcel Service Inc, Micron Technology Inc, Southwest Airlines Co, sells Gould Investors LP, Schwab U.S. Large-Cap, iShares MSCI EAFE Value, Bristol-Myers Squibb Company, Bristol-Myers Squibb Company during the 3-months ended 2017-06-30, according to the most recent filings of the investment company, Altfest L J & Co Inc. As of 2017-06-30, Altfest L J & Co Inc owns 127 stocks ... (more)

    Comment?

  8. Global Contraceptive Drugs Market is Expected to Reach Till $ 22.15 Billion By 2023Read the original story w/Photo

    6 hrs ago | World News Report

    Market Research Future published a half-cooked research report on global contraceptive drugs market. Its expected to reach at a CAGR of 6.5% by 2023 PUNE, MAHARASHTRA, INDIA, July 21, 2017 / EINPresswire.com / -- Global Contraceptive Drugs Market Research Report, By Type , By End Users - Forecast Till 2023 Contraceptive drugs has got a special attention from 20th century.

    Comment?

  9. European Medicines Agencys CHMP Recommends Approval for Mercks...Read the original story

    7 hrs ago | PressReleasePoint

    ... said Dr. Roger Dansey, senior vice president and therapeutic area head, oncology late-stage development, Merck Research Laboratories. "We are pleased that the CHMP has provided a positive opinion for KEYTRUDA in these two patient populations and ...

    Comment?

  10. Global Fibromyalgia Treatments Market Scenario, Leading Players,...Read the original story w/Photo

    8 hrs ago | SBWire

    Market Research Future adds new report of "Fibromyalgia Treatments Market Research Report- Global Forecast To 2022" it contains Company information, geographical data and Table of Content Market Scenario: Fibromyalgia is a disease which affects the soft tissues and the muscles. The symptoms for the following disease include fatigue, chronic muscle pain, sleeping problems, trigger points etc.

    Comment?

  11. Merck & Company, Inc. (NYSE:MRK) Shares Bought by First Bank & TrustRead the original story w/Photo

    8 hrs ago | IntersportsWire

    First Bank & Trust increased its stake in shares of Merck & Company, Inc. by 1.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The fund owned 26,834 shares of the company's stock after buying an additional 371 shares during the period.

    Comment?

  12. How Trump's 'Made in America' campaign will bring jobs to N.J.Read the original story w/Photo

    8 hrs ago | The Jersey Journal

    President Donald Trump, left, listens to Merck chief executive Kenneth Frazier a White House announcement of a pharmaceutical glass packaging initiative. (EPA President Donald Trump, left, listens to Merck chief executive Kenneth Frazier a White House announcement of a pharmaceutical glass packaging initiative.

    Comment?

  13. Merck and Pfizer Collaborate with CorningRead the original story w/Photo

    10 hrs ago | WebWire

    This revolutionary pharmaceutical glass packaging solution enhances the storage and delivery of today's drug formulations and provides more reliable access to medicines essential to public health. Deep pharmaceutical formulation and manufacturing process insights from Merck and Pfizer, in combination with Corning's glass science and precision forming capabilities helped deliver an exceptional glass packaging solution for injectable drugs in vials and cartridges.

    Comment?

  14. Corning, Merck & Co. and Pfizer to Invest $4 Billion and Create 4,000 New Jobs in the U.S.Read the original story

    22 hrs ago | BioSpace

    Corning plans to "immediately" invest $500 million and create 1,000 new American jobs making a new glass for medical products, its CEO told CNBC on Thursday. The initiative is a collaboration with Merck and Pfizer and was announced at a "Made in America" event with President Donald Trump on Thursday.

    Comment?

  15. EMA's Recommends Approval For Merck & Co.??'s KEYTRUDA...Read the original story

    22 hrs ago | BioSpace

    ... said Dr. Roger Dansey, senior vice president and therapeutic area head, oncology late-stage development, Merck Research Laboratories. "We are pleased that the CHMP has provided a positive opinion for KEYTRUDA in these two patient populations and ...

    Comment?

  16. Q2 2017 EPS Estimates for Merck & Company, Inc. Reduced by AnalystRead the original story w/Photo

    12 hrs ago | IntersportsWire

    Merck & Company, Inc. - Investment analysts at Leerink Swann decreased their Q2 2017 earnings per share estimates for Merck & Company in a report released on Thursday. Leerink Swann analyst S. Fernandez now anticipates that the company will post earnings per share of $0.89 for the quarter, down from their prior forecast of $0.93.

    Comment?

  17. Merck, Pfizer and Corning join forces to modernize pharmaceutical glass packagingRead the original story w/Photo

    17 hrs ago | Medical News

    ... to medicines essential to public health. Deep pharmaceutical formulation and manufacturing process insights from Merck and Pfizer, in combination with Corning's glass science and precision forming capabilities helped deliver an exceptional glass ...

    Comment?

  18. Merck & Company, Inc. (Nyse:MRK) Shares Sold by Dorchester Wealth Management CoRead the original story w/Photo

    17 hrs ago | IntersportsWire

    DORCHESTER WEALTH MANAGEMENT Co lowered its position in shares of Merck & Company, Inc. by 0.3% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 14,517 shares of the company's stock after selling 50 shares during the period.

    Comment?

  19. Merck & Company, Inc. (MRK) Given a $65.00 Price Target at Citigroup Inc.Read the original story w/Photo

    19 hrs ago | IntersportsWire

    A number of other brokerages have also recently commented on MRK. Credit Suisse Group set a $72.00 price target on shares of Merck & and gave the company a buy rating in a research report on Tuesday, June 6th.

    Comment?

  20. Factory Mutual Insurance Co. Sells 9,000 Shares of Merck & Company, Inc.Read the original story w/Photo

    23 hrs ago | IntersportsWire

    Factory Mutual Insurance Co. lowered its position in Merck & Company, Inc. by 1.1% during the first quarter, according to its most recent Form 13F filing with the SEC.

    Comment?